| Literature DB >> 15198923 |
Pia K Verkasalo1, Esa Kokki, Eero Pukkala, Terttu Vartiainen, Hannu Kiviranta, Antti Penttinen, Juha Pekkanen.
Abstract
The River Kymijoki in southern Finland is heavily polluted with polychlorinated dibenzo-p-dioxins and dibenzofurans and may pose a health threat to local residents, especially farmers. In this study we investigated cancer risk in people living near the river (less than 20.0 km) in 1980. We used a geographic information system, which stores registry data, in 500 m times 500 m grid squares, from the Population Register Centre, Statistics Finland, and Finnish Cancer Registry. From 1981 to 2000, cancer incidence in all people (N = 188884) and in farmers (n = 11132) residing in the study area was at the level expected based on national rates. Relative risks for total cancer and 27 cancer subtypes were calculated by distance of individuals to the river in 1980 (reference: 5.0-19.9 km, 1.0-4.9 km, less than 1.0 km), adjusting for sex, age, time period, socioeconomic status, and distance of individuals to the sea. The respective relative risks for total cancer were 1.00, 1.09 [95% confidence interval (CI), 1.04-1.13], and 1.04 (95% CI, 0.99-1.09) among all residents, and 1.00, 0.99 (95% CI, 0.85-1.15), and 1.13 (95% CI, 0.97-1.32) among farmers. A statistically significant increase was observed for basal cell carcinoma of the skin (not included in total cancers) in all residents less than 5.0 km. Several other common cancers, including cancers of the breast, uterine cervix, gallbladder, and nervous system, showed slightly elevated risk estimates at less than 5.0 km from the river. Despite the limitations of exposure assessment, we cannot exclude the possibility that residence near the river may have contributed to a small increase in cancer risk, especially among farmers.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15198923 PMCID: PMC1247196 DOI: 10.1289/ehp.6741
Source DB: PubMed Journal: Environ Health Perspect ISSN: 0091-6765 Impact factor: 9.031
Figure 1Exposure zones around the River Kymijoki. Reproduced with permission of the National Land Survey of Finland.
Distribution of people living < 20.0 km from the River Kymijoki in 1980 according to sex, age, SES, distance to sea, and distance to river.
| Variable | No. (%) |
|---|---|
| Sex | |
| Men | 91,687 (48.5) |
| Women | 97,197 (51.5) |
| Age (years) | |
| < 15 | 37,013 (19.6) |
| 15–29 | 44,974 (23.8) |
| 30–44 | 41,621 (22.1) |
| 45–59 | 33,704 (17.8) |
| ≥60 | 31,572 (16.7) |
| SES | |
| Upper-level clerical workers | 22,463 (11.9) |
| Lower-level clerical workers | 40,004 (21.2) |
| Skilled workers | 20,275 (10.7) |
| Unskilled workers | 56,012 (29.7) |
| Farmers | 11,132 (5.9) |
| Unknown | 38,998 (20.6) |
| Distance to the Gulf of Finland (km) | |
| < 20.0 | 100,276 (53.1) |
| 20.0–39.9 | 34,007 (18.0) |
| 40.0–59.9 | 54,601 (28.9) |
| Distance to the River Kymijoki (km) | |
| < 1.0 | 51,723 (27.4) |
| 1.0–4.9 | 82,243 (43.5) |
| 5.0–19.9 | 54,918 (29.1) |
| Total | 188,884 (100.0) |
Risk for total cancer between 1981 and 2000 among all people living < 20.0 km from the River Kymijoki in 1980.
| Distance to the River Kymijoki (km)
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| < 1.0
| 1.0–4.9
| 5.0–19.9
| All people < 20.0
| ||||||||
| Variable | Obs | RR | 95% CI | Obs | RR | 95% CI | Obs | RR | Obs | SIR | 95% CI |
| All sites | 3,866 | 1.04 | 0.99–1.09 | 6,338 | 1.09 | 1.04–1.13 | 4,038 | 1.00 | 14,242 | 0.99 | 0.98–1.01 |
| Sex | |||||||||||
| Men | 1,819 | 1.04 | 0.97–1.11 | 2,979 | 1.10 | 1.03–1.16 | 1,970 | 1.00 | 6,768 | 0.97 | 0.95–0.99 |
| Women | 2,047 | 1.04 | 0.97–1.10 | 3,359 | 1.08 | 1.02–1.14 | 2,068 | 1.00 | 7,474 | 1.01 | 0.99–1.04 |
| Age (years) | |||||||||||
| < 45 | 793 | 1.04 | 0.94–1.15 | 1,351 | 1.10 | 1.00–1.20 | 811 | 1.00 | 2,955 | 0.98 | 0.95–1.02 |
| 45–59 | 1,347 | 1.07 | 0.99–1.16 | 2,277 | 1.11 | 1.04–1.19 | 1,359 | 1.00 | 4,983 | 0.99 | 0.97–1.02 |
| ≥60 | 1,726 | 1.01 | 0.95–1.08 | 2,710 | 1.07 | 1.00–1.13 | 1,868 | 1.00 | 6,304 | 0.97 | 0.97–1.02 |
| Time period | |||||||||||
| 1981–1990 | 1,738 | 1.04 | 0.97–1.11 | 2,746 | 1.07 | 1.01–1.14 | 1,825 | 1.00 | 6,309 | 0.97 | 0.95–1.00 |
| 1991–2000 | 2,128 | 1.03 | 0.97–1.10 | 3,592 | 1.10 | 1.04–1.16 | 2,213 | 1.00 | 7,933 | 1.01 | 0.98–1.03 |
| Distance to the Gulf of Finland (km) | |||||||||||
| < 20.0 | 2,140 | 1.03 | 0.97–1.09 | 3,175 | 1.07 | 1.02–1.12 | 2,816 | 1.00 | 8,131 | 1.04 | 1.02–1.07 |
| 20.0–39.9 | 795 | 1.02 | 0.92–1.14 | 952 | 1.06 | 0.96–1.18 | 510 | 1.00 | 2,257 | 0.92 | 0.88–0.96 |
| 40.0–59.9 | 931 | 1.09 | 0.98–1.20 | 2,211 | 1.15 | 1.06–1.26 | 712 | 1.00 | 3,854 | 0.93 | 0.91–0.96 |
Obs, observed number of cases.
aAll people in Finland were used as reference for SIRs.
Risks for cancer subtypes between 1981 and 2000 among all people living < 20.0 km from the River Kymijoki in 1980.
| Distance to the River Kymijoki (km)
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| < 1.0
| 1.0–4.9
| 5.0–19.9
| All people < 20.0
| ||||||||
| Primary site | Obs | RR | 95% CI | Obs | RR | 95% CI | Obs | RR | Obs | SIR | 95% CI |
| Larynx, epiglottis | 31 | 1.64 | 0.93–2.89 | 35 | 1.15 | 0.66–2.00 | 20 | 1.00 | 86 | 0.88 | 0.70–1.09 |
| Cervix uteri | 39 | 1.61 | 0.97–2.67 | 61 | 1.65 | 1.03–2.64 | 25 | 1.00 | 125 | 1.02 | 0.85–1.22 |
| Gallbladder, bile ducts | 60 | 1.45 | 0.98–2.15 | 83 | 1.34 | 0.93–1.94 | 44 | 1.00 | 187 | 0.90 | 0.77–1.03 |
| Corpus uteri | 128 | 1.20 | 0.93–1.54 | 220 | 1.31 | 1.05–1.65 | 116 | 1.00 | 464 | 1.06 | 0.96–1.16 |
| Lip | 34 | 1.14 | 0.72–1.81 | 44 | 0.99 | 0.64–1.53 | 38 | 1.00 | 116 | 1.06 | 0.88–1.27 |
| Skin, BCC | 1,000 | 1.13 | 1.03–1.24 | 1,566 | 1.13 | 1.04–1.23 | 953 | 1.00 | 3,519 | 1.16 | 1.13–1.20 |
| Ovary | 104 | 1.13 | 0.85–1.49 | 139 | 0.94 | 0.73–1.23 | 98 | 1.00 | 341 | 1.02 | 0.91–1.13 |
| Breast | 554 | 1.12 | 0.99–1.26 | 915 | 1.15 | 1.03–1.28 | 512 | 1.00 | 1,981 | 0.97 | 0.93–1.01 |
| Nervous system | 133 | 1.12 | 0.87–1.43 | 232 | 1.22 | 0.98–1.53 | 124 | 1.00 | 489 | 1.00 | 0.91–1.09 |
| Rectum, rectosigmoid | 162 | 1.09 | 0.88–1.36 | 272 | 1.16 | 0.95–1.41 | 156 | 1.00 | 590 | 1.05 | 0.97–1.14 |
| Stomach | 220 | 1.08 | 0.90–1.31 | 352 | 1.12 | 0.95–1.33 | 224 | 1.00 | 796 | 0.97 | 0.90–1.03 |
| Skin, nonmelanoma | 165 | 1.08 | 0.87–1.34 | 241 | 1.05 | 0.87–1.28 | 176 | 1.00 | 582 | 1.21 | 1.11–1.31 |
| Multiple myeloma | 45 | 1.08 | 0.72–1.63 | 76 | 1.18 | 0.81–1.70 | 47 | 1.00 | 168 | 0.88 | 0.76–1.03 |
| Bladder, ureter, urethra | 143 | 1.05 | 0.83–1.32 | 241 | 1.14 | 0.93–1.40 | 153 | 1.00 | 537 | 0.97 | 0.89–1.06 |
| Non-Hodgkin lymphoma | 102 | 1.03 | 0.78–1.35 | 164 | 1.04 | 0.81–1.33 | 104 | 1.00 | 370 | 1.02 | 0.92–1.13 |
| Prostate | 399 | 1.02 | 0.89–1.17 | 587 | 0.98 | 0.87–1.11 | 444 | 1.00 | 1,430 | 0.97 | 0.92–1.02 |
| Lung, trachea | 396 | 1.00 | 0.87–1.14 | 709 | 1.14 | 1.01–1.28 | 433 | 1.00 | 1,538 | 0.90 | 0.86–0.95 |
| Liver | 51 | 1.00 | 0.68–1.49 | 84 | 1.05 | 0.74–1.50 | 50 | 1.00 | 185 | 1.01 | 0.87–1.17 |
| Kidney | 144 | 0.98 | 0.78–1.23 | 231 | 0.99 | 0.81–1.22 | 159 | 1.00 | 534 | 1.06 | 0.97–1.15 |
| Thyroid gland | 45 | 0.97 | 0.64–1.45 | 75 | 1.00 | 0.69–1.44 | 49 | 1.00 | 169 | 0.76 | 0.65–0.88 |
| Soft tissues | 25 | 0.97 | 0.56–1.67 | 49 | 1.23 | 0.77–1.98 | 28 | 1.00 | 102 | 1.07 | 0.87–1.30 |
| Skin, melanoma | 103 | 0.93 | 0.72–1.22 | 204 | 1.17 | 0.93–1.47 | 119 | 1.00 | 426 | 1.12 | 1.01–1.23 |
| Pancreas | 145 | 0.91 | 0.73–1.14 | 257 | 1.05 | 0.87–1.28 | 171 | 1.00 | 573 | 1.07 | 0.99–1.16 |
| Testis | 14 | 0.91 | 0.44–1.85 | 27 | 1.10 | 0.59–2.04 | 17 | 1.00 | 58 | 1.16 | 0.88–1.49 |
| Colon | 221 | 0.88 | 0.73–1.05 | 390 | 0.99 | 0.84–1.16 | 269 | 1.00 | 880 | 1.05 | 0.98–1.12 |
| Leukemia | 72 | 0.84 | 0.62–1.15 | 141 | 1.06 | 0.82–1.38 | 96 | 1.00 | 309 | 0.96 | 0.86–1.08 |
| Hodgkin disease | 14 | 0.65 | 0.33–1.26 | 38 | 1.11 | 0.66–1.97 | 24 | 1.00 | 76 | 0.87 | 0.68–1.08 |
Obs, observed number of cases.
aAll people in Finland were used as reference for SIRs.
bBCCs of the skin are not included in the total numbers.
Risk for total cancer between 1981 and 2000 among farmers living < 20.0 km from the River Kymijoki in 1980.
| Distance to the River Kymijoki (km)
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| < 1.0
| 1.0–4.9
| 5.0–19.9
| All farmers < 20.0
| ||||||||
| Variable | Obs | RR | 95% CI | Obs | RR | 95% CI | Obs | RR | Obs | SIR | 95% CI |
| All sites | 209 | 1.13 | 0.97–1.32 | 230 | 0.99 | 0.85–1.15 | 704 | 1.00 | 1,143 | 0.96 | 0.91–1.02 |
| Sex | |||||||||||
| Men | 112 | 1.10 | 0.89–1.36 | 123 | 0.95 | 0.77–1.16 | 404 | 1.00 | 639 | 0.92 | 0.85–1.00 |
| Women | 97 | 1.16 | 0.92–1.46 | 107 | 1.04 | 0.83–1.29 | 300 | 1.00 | 504 | 1.01 | 0.93–1.11 |
| Age (years) | |||||||||||
| < 45 | 27 | 1.54 | 0.98–2.42 | 24 | 1.09 | 0.69–1.74 | 70 | 1.00 | 121 | 0.97 | 0.80–1.15 |
| 45–59 | 68 | 1.08 | 0.82–1.42 | 78 | 0.99 | 0.77–1.28 | 246 | 1.00 | 392 | 0.97 | 0.88–1.07 |
| ≥60 | 114 | 1.08 | 0.87–1.33 | 128 | 0.97 | 0.79–1.18 | 388 | 1.00 | 630 | 0.95 | 0.88–1.03 |
| Time period | |||||||||||
| 1981–1990 | 100 | 1.15 | 0.92–1.45 | 115 | 1.08 | 0.87–1.34 | 322 | 1.00 | 537 | 0.96 | 0.88–1.05 |
| 1991–2000 | 109 | 1.11 | 0.89–1.38 | 115 | 0.91 | 0.74–1.13 | 382 | 1.00 | 606 | 0.96 | 0.88–1.04 |
| Distance to the Gulf of Finland (km) | |||||||||||
| < 20.0 | 112 | 1.11 | 0.89–1.38 | 113 | 1.16 | 0.93–1.44 | 279 | 1.00 | 504 | 1.01 | 0.92–1.10 |
| 20.0–39.9 | 67 | 1.11 | 0.85–1.46 | 81 | 0.90 | 0.70–1.16 | 244 | 1.00 | 392 | 0.99 | 0.90–1.10 |
| 40.0–59.9 | 30 | 1.33 | 0.91–1.96 | 36 | 0.80 | 0.56–1.14 | 181 | 1.00 | 247 | 0.83 | 0.73–0.94 |
Obs, observed number of cases.
aAll farmers in Finland were used as reference for SIRs.
Risks for cancer subtypes in 1981–2000 among farmers living < 20.0 km from the River Kymijoki in 1980.
| Distance to the River Kymijoki (km)
| |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| < 1.0
| 1.0–4.9
| 5.0–19.9
| All farmers < 20.0
| ||||||||
| Primary site | Obs | RR | 95% CI | Obs | RR | 95% CI | Obs | RR | Obs | SIR | 95% CI |
| Thyroid gland | 3 | 2.29 | 0.54–9.69 | 3 | 1.70 | 0.41–7.14 | 5 | 1.00 | 11 | 0.79 | 0.39–1.41 |
| Hodgkin disease | 2 | 2.20 | 0.36–13.42 | 2 | 2.02 | 0.34–12.13 | 3 | 1.00 | 7 | 1.06 | 0.42–2.18 |
| Cervix uteri | 1 | 2.04 | 0.18–22.72 | 2 | 2.68 | 0.38–19.08 | 2 | 1.00 | 5 | 0.75 | 0.24–1.76 |
| Ovary | 9 | 1.83 | 0.81–4.12 | 2 | 0.32 | 0.07–1.39 | 18 | 1.00 | 29 | 1.24 | 0.83–1.78 |
| Skin, nonmelanoma | 15 | 1.72 | 0.92–3.19 | 5 | 0.47 | 0.18–1.21 | 32 | 1.00 | 52 | 1.04 | 0.78–1.37 |
| Gallbladder, bile ducts | 3 | 1.72 | 0.43–6.97 | 3 | 1.46 | 0.36–5.86 | 6 | 1.00 | 12 | 0.72 | 0.37–1.26 |
| Rectum, rectosigmoid | 13 | 1.65 | 0.86–3.18 | 7 | 0.69 | 0.30–1.56 | 31 | 1.00 | 51 | 1.07 | 0.80–1.41 |
| Breast | 23 | 1.54 | 0.94–2.52 | 24 | 1.28 | 0.79–2.07 | 55 | 1.00 | 102 | 0.92 | 0.75–1.11 |
| Nervous system | 8 | 1.36 | 0.60–3.07 | 11 | 1.48 | 0.72–3.06 | 22 | 1.00 | 41 | 1.29 | 0.92–1.75 |
| Corpus uteri | 8 | 1.27 | 0.56–2.87 | 8 | 1.01 | 0.45–2.26 | 23 | 1.00 | 39 | 1.17 | 0.83–1.60 |
| Skin, BCC | 56 | 1.26 | 0.93–1.72 | 43 | 0.80 | 0.57–1.12 | 160 | 1.00 | 259 | 1.07 | 0.94–1.21 |
| Stomach | 12 | 1.22 | 0.63–2.35 | 17 | 1.37 | 0.77–2.43 | 38 | 1.00 | 67 | 0.79 | 0.61–1.00 |
| Lung, trachea | 19 | 1.13 | 0.68–1.89 | 26 | 1.18 | 0.75–1.85 | 70 | 1.00 | 115 | 0.78 | 0.64–0.93 |
| Pancreas | 9 | 1.07 | 0.51–2.27 | 11 | 1.05 | 0.53–2.10 | 31 | 1.00 | 51 | 1.14 | 0.85–1.50 |
| Liver | 4 | 1.01 | 0.33–3.08 | 6 | 1.19 | 0.46–3.08 | 15 | 1.00 | 25 | 2.17 | 1.41–3.21 |
| Prostate | 27 | 0.99 | 0.65–1.52 | 32 | 0.92 | 0.62–1.37 | 107 | 1.00 | 166 | 0.99 | 0.84–1.15 |
| Bladder, ureter, urethra | 7 | 0.91 | 0.39–2.08 | 6 | 0.63 | 0.26–1.52 | 30 | 1.00 | 43 | 0.86 | 0.62–1.16 |
| Kidney | 7 | 0.87 | 0.38–1.98 | 13 | 1.31 | 0.68–2.52 | 30 | 1.00 | 50 | 1.24 | 0.92–1.63 |
| Leukemia | 5 | 0.87 | 0.33–2.34 | 9 | 1.33 | 0.61–2.91 | 21 | 1.00 | 35 | 1.19 | 0.83–1.66 |
| Non-Hodgkin lymphoma | 4 | 0.70 | 0.24–2.04 | 3 | 0.40 | 0.12–1.35 | 22 | 1.00 | 29 | 0.99 | 0.66–1.42 |
| Colon | 5 | 0.45 | 0.18–1.15 | 10 | 0.73 | 0.36–1.46 | 40 | 1.00 | 55 | 0.88 | 0.66–1.15 |
| Skin, melanoma | 2 | 0.39 | 0.09–1.96 | 5 | 0.78 | 0.29–2.10 | 19 | 1.00 | 26 | 0.88 | 0.58–1.29 |
| Multiple myeloma | 1 | 0.39 | 0.05–3.10 | 3 | 1.09 | 0.29–4.11 | 8 | 1.00 | 12 | 0.66 | 0.34–1.16 |
| Soft tissues | 3 | NC | NC | 0 | NC | NC | 7 | NC | 10 | 1.29 | 0.62–2.37 |
| Testis | 1 | NC | NC | 0 | NC | NC | 2 | NC | 3 | 1.09 | 0.22–3.18 |
| Larynx, epiglottis | 2 | NC | NC | 0 | NC | NC | 4 | NC | 6 | 0.80 | 0.29–1.73 |
| Lip | 3 | NC | NC | 4 | NC | NC | 4 | NC | 11 | 0.59 | 0.59–1.06 |
Abbreviations: —, models for these cancer subtypes did not converge; NC, models for these cancer subtypes did not converge; Obs, observed number of cases.
aAll farmers in Finland were used as reference for SIRs.
bBCCs of the skin are not included in total numbers.